Collectively, these data along with the finding of sCD137 mRNA induction in CLL B cells by CD40 stimulation suggest that CD137 expression should be induced in tumor cells in the body, resulting in elevated levels of sCD137 in CLL patients. The gene discussed is TNFRSF9; the disease is B-cell chronic lymphocytic leukemia.